Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZYIL1 in Patients With Amyotrophic Lateral Sclerosis
Clinical trial NCT05981040 · COMPLETED
Trial details
- NCT number
- NCT05981040
- Sponsor
- Zydus Lifesciences Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-09
- Primary completion
- 2024-06-26
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.